Emblem Corp was Downgraded to a Hold Rating at GMP FirstEnergy

By Ryan Adsit

In a latest note to investors, a research analyst has provided a rating update for the Healthcare company, Emblem Corp (TSXV: EMC). Analyst Martin Landry from GMP FirstEnergy rated Emblem Corp (TSXV: EMC) a Hold on today, setting a C$1.75 price target.

According to TipRanks.com, Landry is ranked #1147 out of 4619 analysts.

Emblem Corp has an analyst consensus of Moderate Buy, with a price target consensus of C$2.83.

Emblem Corp’s market cap is currently C$126.3M and has a P/E ratio of 0.

Emblem Corp. engages in the provision of pharmaceutical development related to cannabis products. Its activities include cultivation and sale of medical marijuana. The company was founded in 2014 and is headquartered in Toronto, Canada.

The company’s shares closed on Tuesday at C$1.67, close to its 52-week high of C$4.60.